Cardiac troponin autoantibodies in breast cancer patients receiving adjuvant cardiotoxic chemotherapy: the PRADA study
Event:
ESC Cardio-Oncology 2025
Topic:
Research and New Technology
Session:
Insights into anthracycline-induced cardiotoxicity and treatment perspectives
